Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HuangKui capsule for diabetic kidney disease
ChiCTR-IPR-17010335Phase 4Recruiting
- Sponsor
- Jiangsu Provincial Hospital of Traditional Chinese Medicine
- Start
- Jan 2017
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of huang kui capsule in diabetic glomerulosclerosis and type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Jiangsu Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Albumin-to-creatinine ratio (ACR) and 24-hour urine protein. Started Jan 2017; status: recruiting.
02
Drugs
huang kui capsule
03
Conditions
diabetic glomerulosclerosistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-IPR-17010335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010335.